Effects of chemical activation treatment on development of swamp buffalo (Bubalus bubalis) oocytes matured in vitro and fertilized by intracytoplasmic sperm injection.
The objective of this study was to optimize the activation protocol for buffalo oocytes after intracytoplasmic sperm injection (ICSI). The release of the second polar body (PB) at 3, 6 and 9 h after ICSI of in-vitro matured oocytes activated either with 5 μm ionomycin (Io) or with 7% ethanol (EtOH) was preliminary examined. The highest rate of second PB extrusion occurred at 3 h of activation, and the second PB extrusion in EtOH group was significantly higher than that in Io group. Oocytes that extruded the second PB were selected and cultured either with 1.9 mm 6-dimethylaminopurine (6-DMAP) for 3 h or with 10 μg/ml cycloheximide (CHX) for 5 h. Significantly higher rate of oocytes formed 2 pronuclei in EtOH combined with CHX (EtOH + CHX) (62%) group compared to those of Io + CHX (42%) and EtOH + 6-DMAP (48%) groups (p<0.01) whereas Io + 6-DMAP group showed intermediate value (58%). Significantly higher blastocyst formation rates were obtained in Io + 6-DMAP (29%) and EtOH + CHX (24%) groups than in Io + CHX (6%) and EtOH + 6-DMAP (17%) groups. Our results indicate that buffalo ICSI oocytes are effectively activated by combination treatment of Io with 6-DMAP and EtOH with CHX resulting in the highest cleavage and blastocyst formation rates.
Liang
Y Y
YY
Embryo Technology and Stem Cell Research Center and School of Biotechnology, Suranaree University of Technology, Nakhon Ratchasima, Thailand.
Ye
D N
DN
Laowtammathron
C
C
Phermthai
T
T
Nagai
T
T
Somfai
T
T
Parnpai
R
R
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001755:Blastocyst / Q000166:cytology / Q000502:physiology; D002020:Buffaloes; D002452:Cell Count; D002478:Cells, Cultured; D002970:Cleavage Stage, Ovum / Q000502:physiology; D003513:Cycloheximide / Q000494:pharmacology; D046149:Embryo Culture Techniques / Q000662:veterinary; D000431:Ethanol / Q000494:pharmacology; D005260:Female; D015759:Ionomycin / Q000494:pharmacology; D009865:Oocytes / Q000187:drug effects* / Q000502:physiology* / Q000648:ultrastructure; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D020554:Sperm Injections, Intracytoplasmic / Q000662:veterinary*
D047428:Protein Kinase Inhibitors; D000431:Ethanol; D015759:Ionomycin; C001020:N(6),N(6)-dimethyladenine; D003513:Cycloheximide; D000225:Adenine